Improved patient-reported health impact of multiple sclerosis: The ENABLE study of PR-fampridine.
Mult Scler
; 22(7): 944-54, 2016 06.
Article
in En
| MEDLINE
| ID: mdl-26447066
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
4-Aminopyridine
/
Potassium Channel Blockers
/
Patient Reported Outcome Measures
/
Multiple Sclerosis
Type of study:
Clinical_trials
/
Diagnostic_studies
/
Observational_studies
Limits:
Adolescent
/
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
Europa
/
Oceania
Language:
En
Journal:
Mult Scler
Journal subject:
NEUROLOGIA
Year:
2016
Type:
Article
Affiliation country:
Australia